ClassID:

112233

C12N2810/00 - CPC Classification

Classification description:

Vectors comprising a targeting moiety

Sub-classes:
Recent Application in this class:
#1
20250197811
2025-06-19

COMPOSITIONS AND METHODS FOR GENERATING CELLS WITH REDUCED IMMUNOGENICITY

#2
20250121079
2025-04-17

Targeted Protease Compositions and Uses Related Thereto

#3
20240368258
2024-11-07

GRP78-BINDING ANTIBODIES AND USE THEREOF IN DETECTING OR NEUTRALIZING GRP78

#4
20240352489
2024-10-24

METHODS AND COMPOSITIONS FOR MODIFYING A TARGETED LOCUS

#5
20240052365
2024-02-15

METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME

#6
20230416761
2023-12-28

Targeted protease compositions and uses related thereto

#7
20230265452
2023-08-24

Phagemid Vector

#8
20230139913
2023-05-04

Phage-displayed accessible recombinant targeted antibodies and methods of making same

#9
20230028927
2023-01-26

GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78

#10
20220348680
2022-11-03

GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78

#11
20220306763
2022-09-29

GRP78-binding antibodies and uses thereof and selection of phage-displayed accessible recombinant targeted antibodies

#12
20220233715
2022-07-28

AAV MUTANT THAT EFFICIENTLY INFECTS SUPPORTING CELLS

#13
20210301301
2021-09-30

Targeted modification of rat genome

#14
20200291425
2020-09-17

Methods and compositions for the targeted modification of a genome

#15
20190388549
2019-12-26

Targeted protease compositions and uses related thereto

#16
20190323032
2019-10-24

Targeted modification of rat genome

#17
20190225992
2019-07-25

Methods and compositions for modifying a targeted locus

#18
20190112619
2019-04-18

Methods and compositions for the targeted modification of a mouse ES cell genome

#19
20190099453
2019-04-04

Medicament for liver regeneration and for treatment of liver failure

#20
20180320200
2018-11-08

Phagemid vector

#21
20180031572
2018-02-01

Optogenetic probes for measuring membrane potential

#22
20170319658
2017-11-09

Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans

#23
20170211099
2017-07-27

Methods and compositions for modifying a targeted locus

#24
20170204430
2017-07-20

Targeted modification of rat genome

#25
20170067078
2017-03-09

Methods and compositions for the targeted modification of a mouse embryonic stem cell genome

#26
20150376650
2015-12-31

Methods and compositions for modifying a targeted locus

#27
20150285820
2015-10-08

Optogenetic probes for measuring membrane potential

#28
20150159175
2015-06-11

Methods and compositions for the targeted modification of a genome

#29
20150159174
2015-06-11

Methods and compositions for the targeted modification of a mouse genome

#30
20140370500
2014-12-18

Nonviral targeted nanoparticle system for gene transfer and drug delivery

#31
20120315322
2012-12-13

NANOPARTICLE MEDIATED GENE THERAPY AND THERAPEUTIC PRODUCTS FOR ALZHEIMERS

#32
20120015899
2012-01-19

MODIFIED PLANT VIRUS PARTICLES AND USES THEREFOR

#33
20110274706
2011-11-10

NUCLEIC ACID DELIVERY VEHICLE AND USES THEREOF

#34
20100278863
2010-11-04

Reoviruses

#35
20090280089
2009-11-12

Inhibition of the liver tropism of adenoviral vectors

#36
20090018098
2009-01-15

TARGETING THE ABSENCE: HOMOZYGOUS DNA DELETIONS AS SIGNPOSTS FOR CANCER THERAPY

#37
20070275924
2007-11-29

Synthetic lipid rafts and methods of use

#38
20070196338
2007-08-23

Heparin and heparan sulfate binding chimeric vectors

#39
20060110376
2006-05-25

MDA-7 and free radicals in the treatment of cancer

#40
20050091702
2005-04-28

Expression of polypeptides in rod outer segment membranes